Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Didn't he mention something about an announcement about the UK market coming soon? He did mention something about sales going well in Western Europe.
However, his brushing off of the US market (he said that is just 1/3 of their overall market strategy) told me everything I suspected - No FDA approval anytime soon.
And that is what this has come down to now - an FDA play. Intl. sales will have to blow the shudders off this thing for the stock to go back to .03.
Your last paragraph has some really good questions.
If you look up MFLI on Google Finance, it has the old CEO and senior management team still listed (you would think someone would update it). I've never heard the story of how the company changed hands and how Danny took control. I came into this in September, months after that happened.
As for your prediction about the coming announcements, I hope it isn't something about some deal struck with Mel B. While I don't have a problem with her, that would not exactly excite the market.
I just hope to God the announcements are truly signficant. I'm not sure they will be after some of the recent ones.
He's excruciating to listen to. Not the greatest ambassador for a company. Comes across as washed up and burned out to me. He did do a better audio interview earlier this year.
The venue (stockgoodies) was as bush league as it comes. There are so many better outlets for an interview.
I'll say this for Mel B (and even Pam). At least they showed up (although in Pam's case, just physically).
Denise Richards and Audrina Partridge didn't even bother.
I don't have a problem with Pam but remember that Danny mentioned a possible affiliation with her and Carmen Electra in the last conference call. It wasn't some accident that she showed up. She accepted the invitation.
Obviously she wasn't sure what Bravada was all about as seen in the interview.
All I care about is store sales.
Nice new Google map of the store location at bravadaltd.com.
Pretty soon Danny will have to have multiple Google maps on his site because he'll have multiple Bravada outlets. That's multiple cash registers ringing in various locales.
BravadaWomen.com is climbing the traffic chart online. The past month, traffic has increased 160%. At last metric, it ranked 242,000 on the vast WWW. That might not sound like a big deal, but once you crack the top 100,000 worldwide, it's big. And this includes all WWW sites, including porn sites, blog sites, etc.
BravadaWomen.com ranks in the top 24,800 for USA Internet traffic.
If the right opinion leaders in Hollywood start speaking positively about the Bravada store, look out!
Word is out on the other board that Noel is out as the PR guy.
I must say I really wonder about Noel. He reminds me of a carnival barker.
This whole thing smells bad now. The smart money left long ago. All I can say is thank God I didn't risk everything on this.
I don't trust either Whelan or Noel.
And surprise, surprise, this was another BioMedReports stock. The ultimate pump and dump machine.
Just my opinions.
This will only spike again on FDA approval. If you think that's coming soon consider this - they still have not even filed the new dossier.
Anyone who thinks OTCBB or Joe Noel's b.s. posts alone are going to move this stock back to .03 or higher, they're delusional. Noel is only driving the PPS downward because he can't be trusted anymore.
October is in 4 months not 5. I know it's hard to calculate that.
Hope your math skills are better with your stock picks. I see by your handle you are familiar picking other things.
He reads pretty well. 9PM PST is Midnight Eastern. So it would be Midnight in NY, Philly, NJ, DC, Atlanta, Miami, Boston.
I think that's why he's laughing.
Terrific potential here with Clinuvel. I've been in this stock since 2003, and have been following the research since 1990.
More info is available at Clinuvel.com and melanotan.org.
The more you research this amazing drug, the more you'll see its potential.
Keep the board clean and helpful.
Nice work. Somebody gets it.
Hopefully ClayTrader will pop in here for his video chart.
You out there, Clay?
But we've haven't closed above .02 since Danny released the sizzle reel in late March.
It is a magic numero.
.02 is a significant level. MFLI has not closed above it since the selloff that took place when Danny first released the sizzle reel at the end of March.
We need to pierce that .02 ceiling and close above it in the coming days.
I'm also from the old MTV generation - was weened on early MTV - 1981-1984.
Younger demographic is great, but I want Danny to make sure he still appeals to the slightly older crowd as well - tons of discretionary income for those 28-44.
But with social networking, this younger audience can spread the word about VATA in a heartbeat if they like their clothes.
For my personal tastes, I prefer Cavallari from The Hills:
http://www.google.com/images?hl=en&q=the%20hills%20cavallari&um=1&ie=UTF-8&source=og&sa=N&tab=wi
Good Lord - now there's a woman who would rock any man's world.
Patridge is better for the stock, but Cavallari is one of the few Hollywood celebs that gets a liftoff from me.
I'm starting to think that MFLI is becoming more of longer hold than something that will spike to .04+ over a week or two like it did a few months back. I don't think that will happen in the next couple weeks.
That might be a good thing for the long haul. We'll get to .05 eventually. The most important thing is for Danny to be building a growth business, and so far it looks promising.
Funny, I just posted the same thing before reading your post.
Pam and Carmen are fading stars - I'd prefer Danny go after the younger demographic.
I like that Danny is going after a younger demographic, and I'd prefer the younger chicks like this to has-beens such as Pam Anderson and Carmen Electra, but T Lopez is not a huge hit with the young girls yet. Her YouTube videos only have about 10k hits. That is very low compared with other up-and-coming girls in her class.
I'm very happy and impressed that Danny got a TCP deal, but he's laid himself out there by saying that shareholders who think they know what's coming next Thursday don't have a clue.
If it's the expected (E! or Bravo deal for TCP), then the surprise could be in a negative way the market reacts (ho hum).
I'm not saying that's the way it should be or that Danny has not created value here (I think he has), but he's now in a position of having to really deliver something unexpectedly good.
Not for me, but for the others who are not currently invested in this.
The Superior Stocks $5k payment was a waste of money - it didn't drive the share price this time. That payment could have gone for 2 months of lease at the new store.
The market is already expecting a TCP deal, so I'm not expecting this to rocket next week.
And by the way, I've been in this before Danny even had any employees, so I've been around the block with MFLI.
More of a longer-term hold now than a June trade IMO.
Oh boy! SkyMark!
The same outfit that recommended TSHO and even after it went from $1.60 down to .30 didn't tell its followers to sell is now covering PWRM.
Aren't you all excited??
I can pick my own stocks without reading their "coverage"
Oh boy! SkyMark!
The same outfit that recommended TSHO and even after it went from $1.60 down to .30 didn't tell its followers to sell is now covering PWRM.
How about staying away from our stock SkyMark!!!
Maybe so, I'm still holding, but I'm not at all happy with how delayed the Phase II results are.
Back in February, Biomoda's CEO said Phase II results would be out in 3-4 weeks.
That was b.s.
They lost a lot of credibility there. Once a biotech starts that stuff, I'm no longer loyal.
Saw this bumper sticker today...
HONK if you're excited about MFLI
...on my own car!
Danny if you're not already selling the VATA activewear on Yahoo Shopping, I'd highly recommend it. I got good results from that when I had an online merchandise store.
It also helps your search rankings in Yahoo to have items in Yahoo Shopping.
Here's hoping we get the big ann. next week. I'm beginning to think it's now coming in June since Danny says June will be full of surprises.
Attn: Danny
With your official name, "BRAVADA - Women's Athletica," I can see merchandising potential of t-shirts, sweatshirts, sweatpants, etc. with the Bravada - Women's Athletica logo splashed across those items - similar to what Old Navy and Abercrombie & Fitch has done.
Cha-ching.
DO you have a newsletter, mercurialmike?
You can sure pick winners! Like MCLN. Got any others for the faithful followers?
I'm sure MCLN was your only losing pick!
Your picks are sweeping the nation.
You're here to trash my posts because you're upset that I called MCLN a dog. Which I was right about.
Now, instead of admiting you were wrong about another stock, you want to try to cause trouble on this board and trash others.
Unexpectedly discovered new and unprecedented findings.
HOUSTON, May 20, 2010 (BUSINESS WIRE) -- Power3 Medical Products, Inc. (PWRM, Trade ) announced today that, in collaboration with Lourdes R. Bosquez, MD, it has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro(R) protein biomarkers in the blood of untreated Alzheimer's disease patients compared to patients treated with the widely used anti-dementia drugs Aricept(R) (Donepezil HCl, Pfizer -- NYSE: PFE), Exelon(R) (Rivastigmine, Novartis -- NYSE: NVS), and Namenda(R) (Memantine HCl, Forest Laboratories -- NYSE: FRX). These results relate to the genetically distinct groups of Alzheimer's disease patients, i.e., those individuals who possess the Alzheimer's high-risk gene for Apolipoprotein E4 and those who do not possess the gene.
NuroPro(R) was originally indicated for diagnostics to determine whether or not a patient had Alzheimer's disease. With these results, NuroPro(R) now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment, including the underlying disease process and the insidious progression of irreversible neurological damage, even in the face of temporary improvements in cognition and other symptoms.
Power3 has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the world's most prestigious peer-reviewed scientific journals. Power3 also plans to demonstrate the clinical application and benefits of its NuroPro(R) diagnostic tests to healthcare providers located throughout the world. Power3 believes that this will assist the company greatly in an effort to generate sales of its NuroPro(R) diagnostic tests. Power3 is currently working on a joint distribution effort with a number of potential business partners, such as the companies mentioned above, for the sale of its NuroPro(R) diagnostic tests and the development of new drugs.
"This new and amazing discovery will help clarify some of the clinical observations and overcome difficulties that we have had as physicians, not only by helping us choose more appropriate treatment and better predict response, but also by helping us find more permanent treatments for the dementias," said Dr. Bosquez.
Ira L. Goldknopf, Ph.D., President and Chief Scientific Officer of Power3, stated, "This innovation will provide physicians with an invaluable perspective to use in the treatment of their patients and will have profound implications for the diagnosis and treatment of Alzheimer's disease, and for other diseases as well."
Mr Millions, I hope Power 3 comes after you. You have gone too far.
BTW, you are doing the same thing on MFLI's board and others.
You were dead wrong about MFLI and PWRM. You said PWRM was going to .02 and it went to .07 last month.
Give it up. You don't know what you're talking about. I have alerted the company to your posts here an on Yahoo. You're on notice.
Your bus is about to take a trip into subpenny land.
Another great BMR pick.
Yes, he's been busy...busy making terrible calls on stocks. Check out "marcos" post on his blog before Noel removes it. He lists about 15 stocks that Noel features, and the negative returns on them are unreal.
Anything Noel recommends I avoid like the plague. BIEL is the one exception.
Danny said back in March they were hoping for this summer. It is getting very late for that...
Then I wonder why Ken Collis said historic week (this week) and mentioned TCP?
Bravada vs. Sunset Tan.
In many ways, Bravada reminds me of SunsetTan (http://www.sunsettan.com/company.php).
Sunset Tan as most of you know had a reality show on E! (which bit), opened a flagship store in LA, opened a couple other area stores, and is trying to franchise. And it was run by a couple overaged guys who were trying to dress and look like college kids.
I looked over Sunset Tan story more closely to see if it was a publicly traded company. I wanted to see how their reality show might have impacted the share price. The interesting thing is Sunset Tan was never publicly traded.
Which makes it even more intriguing to see how the upcoming reality show for Bravada will influence the stock price. So far, we have no investment model that we can compare it to. There has not been to my knowledge a reality show built around a small, but growing publicly traded company like Bravada.
You mean it's not going to .40?
You finally see the light, but you held the bag too long. Tried tellin 'ya.
This was another winner from Garza. Just shy of his .40.
Enjoy.
Hey - Check out this even better view of the soon-to-be Bravada store.
Go to:
http://maps.google.com/
Put this address in the "searh maps" field
322 S Robertson Blvd, Los Angeles, California 90048
Then if you drag the "yellow guy" icon over the Robertson Bvld blue line in the street (Google Street View), it's like you're right there.
Danny's shop is the one right next to the alley. The old store had "avedon" signage - the palm tree blocks out the first letter of the old store's sign.
It's getting harder to move the needle on this now. The company is in a much better position than it was last time we hit .043 - but the share price still hasn't gotten over .02 since the original sizzle reel was put out at the end of March.